A Structure-Based View on ABC-Transporter Linked to Multidrug Resistance

10.01.2023

Happy New Year! 2023 is already off to a great start with the first published paper this year.

Huang, J.; Ecker, G.F. A Structure-Based View on ABC-Transporter Linked to Multidrug Resistance. Molecules 2023, 28, 495.

DOI

https://doi.org/10.3390/molecules28020495

Abstract

The discovery of the first ATP-binding cassette (ABC) transporter, whose overexpression in cancer cells is responsible for exporting anticancer drugs out of tumor cells, initiated enormous efforts to overcome tumor cell multidrug resistance (MDR) by inhibition of ABC-transporter. Because of its many physiological functions, diverse studies have been conducted on the mechanism, function and regulation of this important group of transmembrane transport proteins. In this review, we will focus on the structural aspects of this transporter superfamily. Since the resolution revolution of electron microscope, experimentally solved structures increased rapidly. A summary of the structures available and an overview of recent structure-based studies are provided. More specifically, the artificial intelligence (AI)-based predictions from AlphaFold-2 will be discussed.

Rights & permissions

Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://cre‐ ativecommons.org/licenses/by/4.0/).

Keywords

structure‐based studies; ABC transporter; multidrug resistance (MDR); cancer therapy

 

 

© 2023 by the authors. Li‐

censee MDPI, Basel, Switzerland.

 More News

Project
 

The whole RISK-HUNT3R consortium convened in June in Helsinki for a truly energizing week, bringing together project members and stakeholders to shape...

News
 

In this interview in the course of the VITALITY project, Gerhard Ecker talks about the aim to reduce the number of animal experiments by doing early...

News
 

The AI4Health project, a joint initiative by Robimo GmbH, spin-off of the University of Vienna, and the Pharmacoinformatics Research Group led by...